Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity Study of SB16 in Healthy Male Subjects
Status:
Recruiting
Trial end date:
2021-08-03
Target enrollment:
Participant gender:
Summary
This study is to compare PK, PD, safety, tolerability, and immunogenicity profiles of SB16,
EU sourced Prolia, and US sourced Prolia in healthy male subjects.